Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 10:13:810576.
doi: 10.3389/fmicb.2022.810576. eCollection 2022.

Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern

Affiliations

Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern

Dàlia Raïch-Regué et al. Front Microbiol. .

Abstract

The SARS-CoV-2 antigen-detecting rapid diagnostic test (Ag-RDTs) is an easy-to-use diagnostic tool to identify the contagious individuals and reduce the new infections. However, to be effective, Ag-RDTs require the detection of distinct variants of concern (VOC) with high analytical sensitivity. Here, we found that the VOC diverge at the nucleocapsid protein used by four commercial Ag-RDTs for the viral detection. Relative to the original D614G variant, there was a 10-fold loss of detection for the Delta and Alpha variants in certain Ag-RDTs, a reduction above the threshold required to isolate the viable virus. However, Beta and Omicron variants did not lose the detection capacity. As the new VOC arise, successful contact tracing requires continuous monitoring of Ag-RDTs performance.

Keywords: SARS-CoV-2; antigen-detecting rapid diagnostic tests; diagnosis; nucleocapsid (N); variants of concern.

PubMed Disclaimer

Conflict of interest statement

NG, AC, and FG were employed by company Nesapor Europa. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declare that this study received funding from Nesapor. The funder had the following involvement in the study: sponsored the research activity and contributed with the input of their employees.

Figures

FIGURE 1
FIGURE 1
Nucleocapsid mismatches and quantification of the SARS-CoV-2 variants. (A) Nucleotide mismatches or deletions (represented by the colored lines of the legend) and amino acid changes indicated by codon position sequenced in the nucleocapsid of distinct SARS-CoV-2 variants as compared to the original Wuhan virus (as reference). (B) Nucleocapsid concentration measured by qPCR (log10 of viral N2 RNA copies/ml) and ELISA (ng of nucleocapsid/ml) for all variants analyzed at the first dilution tested in the Ag-RDTs.
FIGURE 2
FIGURE 2
Comparative detection of SARS-CoV-2 variants by four commercial Ag-RDTs and correlation with nucleocapsid copies per ml. (A) Detection of 4 VOC using a 1:19 ratio of sample-to-buffer volume (10 μl:190 μl). (B) Detection of six variants using a 1:1 ratio of sample-to-buffer volume (100 μl:100 μl). The results for 1/10 viral dilutions tested in duplicate are indicated for each variant and commercial Ag-RDTs. Red boxes indicate variant-Ag-RDTs combination with reduced detection capacity as compared to D614G. (C) The detection range shown as values of the viral N2 RNA (in log10 of copies/ml). The range above the first 10-fold dilution with positive results of detection is shown in green, while the range below the first 10-fold dilution with negative results is depicted in red for each Ag-RDTs and every variant at the ratio 1:1.

References

    1. Alemany A., Baró B., Ouchi D., Rodó P., Ubals M., Corbacho-Monné M., et al. (2021). Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test. J. Infect. 82 186–230. 10.1016/j.jinf.2020.12.033 - DOI - PMC - PubMed
    1. CDC (2019). CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel. Available online at: https://www.fda.gov/media/134922/download - PMC - PubMed
    1. Ge Y., Martinez L., Sun S. (2021). COVID-19 Transmission Dynamics Among Close Contacts of Index Patients With COVID-19: a Population-Based Cohort Study in Zhejiang Province, China. JAMA Intern. Med. 181 1343–1350. 10.1001/jamainternmed.2021.4686 - DOI - PMC - PubMed
    1. Lange B., Gerigk M., Tenenbaum T. (2021). Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers. N. Engl. J. Med. 385 1145–1146. 10.1056/NEJMc2108076 - DOI - PMC - PubMed
    1. Li B., Deng A., Li K. (2021). Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant. medRxiv. 2021.07.07.21260122 [Preprint]. 10.1038/s41467-022-28089-y - DOI - PMC - PubMed

LinkOut - more resources